I’ve noted the warnings about remdesivir as explained by Dr. Bryan Ardis, which is why I’ve labeled this the “Pandemic of Medical Malpractice.”
As previously reported:
To understand the severity of this scandal, let’s briefly review some background of how Remdesivir came into use for COVID-19.
Remdesivir is a nucleotide analogue prodrug originally developed for the treatment of Ebola virus.
A New England Journal of Medicine study claimed that a single United States COVID-19 patient showed improvement after taking Remdesivir.
Coincidentally, the Wuhan Institute of Virology sought a patent for the use of Remdesivir.
But at the height of COVID-19, the NIH picked Remdesivir as the gold standard treatment for COVID-19.
Anthony Fraudci cited the drug’s effectiveness against Ebola as the reasoning for its use against this novel coronavirus.
Fraudci used this New England Journal of Medicine study to back his claims.
A closer look at this study below:
On August 9, 2019, when 681 patients had been enrolled, the data and safety monitoring board conducted an interim analysis on data from 499 patients and, on the basis of two observations, recommended terminating random assignment to ZMapp and remdesivir.
Remdesivir was pulled from the study due to 53.1% of recipients dying from the drug.
Who supported that study?
The NIH & NIAID.
Another New England Journal of Medicine study Fraudci used to push Remdesivir as a COVID-19 treatment analyzed 53 patients from the United States, Canada, Europe, and Japan.
This is what the study found:
Seven of the 53 patients (13%) died after the completion of remdesivir treatment, including 6 of 34 patients (18%) who were receiving invasive ventilation and 1 of 19 (5%) who were receiving noninvasive oxygen support (see the Supplementary Appendix for case narratives). The median interval between remdesivir initiation and death was 15 days (interquartile range, 9 to 17).
A total of 32 patients (60%) reported adverse events during follow-up (Table 2). The most common adverse events were increased hepatic enzymes, diarrhea, rash, renal impairment, and hypotension. In general, adverse events were more common in patients receiving invasive ventilation. A total of 12 patients (23%) had serious adverse events. The most common serious adverse events — multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypotension — were reported in patients who were receiving invasive ventilation at baseline.
Despite these alarming studies, Remdesivir was pushed on the general public as the standard hospital protocol for COVID-19 patients.
Cheap, off-label drugs like Hydroxychloroquine (HCQ) and Ivermectin were targeted in a vicious smear campaign.
The antiviral drug manufactured by Gilead Sciences has remained the central component of COVID-19 protocols for hospitalized patients.
But the toxic drug is responsible for catastrophic side effects like multi-organ-dysfunction syndrome and kidney failure.
Even more disturbing, hospitals have received bonuses to prescribe remdesivir for COVID-positive Medicare patients.
Today, I’ve learned that Maryland Governor Larry Hogan (R) announced the Maryland National Guard will distribute remdesivir to pharmacies that directly serve nursing homes.
Governor Hogan has the notice buried in this Twitter thread that started with the distribution of N95 and K95 masks.
Over the next few days, the @MDNG will begin distributing courses of Remdesivir, which is one of the therapeutic treatments believed to be effective against the Omicron variant, to institutional pharmacies that directly serve nursing homes.
— Governor Larry Hogan (@GovLarryHogan) January 13, 2022
Governor Hogan announced the distribution of remdesivir at a press conference.
Watch the video below via Rumble:
Just gonna leave this right here. If you have a loved one in a Maryland nursing home, heads up. https://t.co/QRPkiKTpDe
— NurseClaire (@NurseClaire2) January 14, 2022
Governor Hogan of Maryland yesterday.
National Guard to distribute remdesivir to elderly care facilities.
Opening 16 new state run testing sites at hospitals
Dept of health and NG to distribute 20 million masks.
REMDESIVIR TO THE ELDERLY. WTAF. CRUEL and ABUSIVE pic.twitter.com/iRQjpEKsvT
— Allie 🙏🏼❤️💪🇺🇸 (@Allie4Freedom) January 14, 2022
Gov. Hogan is putting Covid patients on death row with remdesivir. It shuts their kidneys down, they get pneumonia, keep them bed-ridden, and then the death-a-later (vent).
Governor Hogan of Maryland yesterday.
Covid isn’t killing, CDC guidelines for treatment is the killer. pic.twitter.com/xZ2LgGIWqJ
— ꧁ঔৣ✞ᑭᗩᔕtoᖇ ᗰᗩᖇty✞ঔৣ꧂ (@CT_Preacher) January 14, 2022
CBS 13 Baltimore wrote:
Nursing home visitors will need to provide proof of a negative test or take a rapid test at the facility before seeing their loved ones, Hogan said. Those testing resources will be made available to them free of charge.
To further combat COVID-19, the Maryland National Guard will begin distributing Remdesivir to pharmacies that directly serve nursing homes, Hogan said. Remdesivir is a therapeutic treatment that has proven to be effective against the Omicron variant, which has proven to be four to five times more transmissible than other COVID-19 variants.
“From day one of this crisis, we have taken unprecedented actions to bring our entire public health arsenal to bear against this virus,” the governor said. “This includes procuring and distributing hundreds of millions of gowns, masks and other [personal protective equipment].”
Maryland is under a 30-day state of emergency issued by Hogan in response to surging cases and hospitalizations, some of which have declared disasters and shifted to crisis protocols to keep up with demand for care.
Remdesivir is a dangerous therapeutic, and Governor Hogan is putting Maryland nursing residents directly in harm’s way.
And COVID-19 will likely receive the blame for any casualties caused by the side effects of the antiviral drug.
Please share this urgent warning to anyone you know with a loved one in a Maryland nursing home!